Galaxy Medical is developing Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias
Location: United States, California, San Carlos
Employees: 11-50
Total raised: $18M
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Apple Tree... | appletreep... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.03.2021 | - | $18M | - |
Mentions in press and media 11
| Date | Title | Description |
| 20.09.2022 | How 3 companies merged and raised $100M to treat range of diseases by pulsing cells (San Francisco Business Times) | By Ron Leuty Republished with permission from San Francisco Business Times Three related companies are coming together as one to develop pulsed electric field therapies — basically using energy to make cells do what doctors want them to d... |
| 15.09.2022 | Galvanize Therapeutics Announces Merger to Create the Premier Pulsed Electric Field Therapy Company and Completion of $100 Million Series B Financing | Merger unites three companies created by life sciences venture capital firm ATP—Gala Therapeutics, Galaxy Medical, and Galvanize Therapeutics—to create a single company based on the AliyaTM Pulsed Electric Field (PEF) energy platform Galva... |
| 20.09.2021 | Galaxy Medical Enrolls First Patients in SPACE-AF Study | SAN CARLOS, Calif., Sept. 20, 2021 /PRNewswire/ -- Galaxy Medical announced today the initiation of the SPACE-AF study with enrollment of the first two patients at Southlake Regional Health Centre in Newmarket, Canada. In the study, the CEN... |
| 20.09.2021 | Galaxy Medical Enrolls First Patients in SPACE-AF Study | SAN CARLOS, Calif., Sept. 20, 2021 /PRNewswire/ -- Galaxy Medical announced today the initiation of the SPACE-AF study with enrollment of the first two patients at Southlake Regional Health Centre in Newmarket, Canada. In the study, the CEN... |
| 28.07.2021 | Galaxy Medical Releases ECLIPSE-AF Remapping Data at Stanford Biodesign Retreat and Update on System Interoperability | SAN CARLOS, Calif., July 28, 2021 /PRNewswire/ -- Galaxy Medical announced today that the ECLIPSE-AF 90-day remapping data, presented at the Stanford BioDesign New Arrhythmia Technologies retreat, demonstrated durable lesions and chronic pu... |
| 28.07.2021 | Galaxy Medical Releases ECLIPSE-AF Remapping Data at Stanford Biodesign Retreat and Update on System Interoperability | SAN CARLOS, Calif., July 28, 2021 /PRNewswire/ -- Galaxy Medical announced today that the ECLIPSE-AF 90-day remapping data, presented at the Stanford BioDesign New Arrhythmia Technologies retreat, demonstrated durable lesions and chronic pu... |
| 28.07.2021 | Galaxy Medical Releases ECLIPSE-AF Remapping Data at Stanford Biodesign Retreat and Update on System Interoperability | |
| 12.05.2021 | Galaxy Medical and Japan Lifeline Enter Distribution Agreement For Novel Pulsed Electric Field Focal Ablation Catheter | SAN CARLOS, Calif., May 12, 2021 /PRNewswire/ -- Galaxy Medical (Galaxy) and Japan Lifeline (JLL) today announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the United States, developed by Japan Lifeline for use... |
| 16.03.2021 | Galaxy Medical Receives $18 Million from ATP to Advance Development of Its Novel Pulsed Electric Field Ablation Therapy for Cardiac Arrhythmias | Galaxy's proprietary CENTAURI™ system on track for EU registration and US pivotal trial start later this year; shows best-in-class potential SAN CARLOS, Calif., March 16, 2021 /PRNewswire/ -- ATP, a leader in life science venture capital, ... |
| 08.10.2020 | First Patients Treated with Galaxy Medical’s CENTAURI™ Pulsed Electric Field Cardiac Ablation System | San Carlos, CA, October 8, 2020 – Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients in the ECLIPSE-AF study were successfully treated with... |
Show more